Is MNKD Worth Buying in 2026?

Mannkind Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Mannkind Corporation (MNKD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+7.88% over 10 days); RSI 59 — healthy momentum range; 3-month momentum positive (+32.1%). Concerns: trading below the 200-day MA (long-term downtrend); declining volume on rally — weak conviction (0.68x 30d avg). Currently 43.8% off its 52-week high. Score: +1/7.

Ready to act on this? 📈 Trade on Webull

MNKD is trading below its 200-day MA ($4.55) — a key warning sign the longer-term trend is under pressure. An RSI of 59.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -4.4% compares to +22.9% for SPY (trailed the market by 27.3%). The current 43.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $9,556 today
vs. S&P 500 (SPY) — same period trailed market by 27.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($4.55)
Above 50-day MA ($3.10)
RSI(14) neutral zone (30–70) — currently 59.1
Positive return (-4.4%)
!Within 10% of period high (−43.8%)
Period Range $3.66
$2.23 $6.51
RSI (14) 59.1
0 · OversoldOverbought · 100

Key Metrics

Price$3.66
Period Return-4.4%
Period High$6.51
Period Low$2.23
Drawdown−43.8%
MA-50$3.10
MA-200$4.55
RSI (14)59.1
Avg Volume (30d)6.6M
vs. SPYtrailed by 27.3%
Return Rank#736 of 1246

Trade MNKD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers